Literature DB >> 19004849

The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis.

Meral Kayikcioglu1, Murat Tumuklu, Mehmet Ozkahya, Oner Ozdogan, Gulay Asci, Soner Duman, Huseyin Toz, Levent H Can, Ali Basci, Ercan Ok.   

Abstract

BACKGROUND: Most haemodialysis (HD) centres use anti-hypertensive drugs for the management of hypertension, whereas some centres apply dietary salt restriction strategy. In this retrospective cross-sectional study, we assessed the effectiveness and cardiac consequences of these two strategies.
METHODS: We enrolled all patients from two dialysis centres, who had been on a standard HD programme at the same centre for at least 1 year. All patients underwent echocardiographic evaluation. Clinical data were obtained from patients' charts. Centre A (n = 190) practiced 'salt restriction' strategy and Centre B (n = 204) practiced anti-hypertensive-based strategy. Salt restriction was defined as managing high blood pressure (BP) via lowering dry weight by strict salt restriction and insistent ultrafiltration without using anti-hypertensive drugs.
RESULTS: There was no difference regarding age, gender, diabetes, history of cardiovascular disease and efficiency of dialysis between centres. Antihypertensive drugs were used in 7% of the patients in Centre A and 42% in Centre B (P < 0.01); interdialytic weight gain was significantly lower in Centre A (2.29 +/- 0.83 kgversus 3.31 +/- 1.12 kg, P < 0.001). Mean systolic and diastolic blood pressures were similar in the two centres. However, Centre A had lower left ventricular (LV) mass (indexed for height(2.7): 59 +/- 16 versus 74 +/- 27 g/m(2.7), P < 0.0001). The frequency of LV hypertrophy was lower in Centre A (74% versus 88%, P < 0.001). Diastolic and systolic functions were better preserved in Centre A. Intradialytic hypotension (hypotensive episodes/100 patient sessions) was more frequent in Centre B (11 versus 27, P <0.01).
CONCLUSIONS: This cross-sectional study suggests that salt restriction and reduced prescription of antihypertensive drugs may limit LV hypertrophy, better preserve LV functions and reduce intradialytic hypotension in HD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004849     DOI: 10.1093/ndt/gfn599

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  55 in total

Review 1.  Dry-weight: a concept revisited in an effort to avoid medication-directed approaches for blood pressure control in hemodialysis patients.

Authors:  Rajiv Agarwal; Matthew R Weir
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

2.  Changes in arterial stiffness following dialysis in relation to overhydration and to endothelial function.

Authors:  Simona Hogas; Serban Ardeleanu; Liviu Segall; Dragomir Nicolae Serban; Ionela Lacramioara Serban; Mihai Hogas; Mugurel Apetrii; Mihai Onofriescu; Radu Sascau; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-03-19       Impact factor: 2.370

Review 3.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

4.  Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients.

Authors:  Manuela Ferrario; Jochen G Raimann; Brett Larive; Andreas Pierratos; Stephan Thijssen; Sanjay Rajagopalan; Tom Greene; Sergio Cerutti; Gerald Beck; Christopher Chan; Peter Kotanko
Journal:  Blood Purif       Date:  2015-07-04       Impact factor: 2.614

5.  Probing dry-weight improves left ventricular mass index.

Authors:  Rajiv Agarwal; J Michael Bouldin; Robert P Light; Ashok Garg
Journal:  Am J Nephrol       Date:  2010-12-13       Impact factor: 3.754

Review 6.  Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy.

Authors:  Xiaoliang Wang; Jiang Liu; Christopher A Drummond; Joseph I Shapiro
Journal:  Expert Opin Ther Targets       Date:  2017-04-03       Impact factor: 6.902

Review 7.  A brief review of intradialytic hypotension with a focus on survival.

Authors:  Jason A Chou; Kamyar Kalantar-Zadeh; Anna T Mathew
Journal:  Semin Dial       Date:  2017-06-29       Impact factor: 3.455

Review 8.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

9.  Effect of Tenapanor on Interdialytic Weight Gain in Patients on Hemodialysis.

Authors:  Geoffrey A Block; David P Rosenbaum; Maria Leonsson-Zachrisson; Bergur V Stefansson; Tina Rydén-Bergsten; Peter J Greasley; Susanne A Johansson; Mikael Knutsson; Björn C Carlsson
Journal:  Clin J Am Soc Nephrol       Date:  2016-06-23       Impact factor: 8.237

Review 10.  Diastolic heart failure: a confusing concept.

Authors:  Evert J Dorhout Mees
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.